Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis. [PDF]
Silva SC +4 more
europepmc +1 more source
Evaluation of Elexacaftor/Tezacaftor/Ivacaftor-Mediated Drug-Induced Liver Injury Using a Liver-On-Chip Model. [PDF]
Shi A, Agarwal P, Liu ZX, Beringer PM.
europepmc +1 more source
Advances in the restoration of CFTR in children and pwCF with "mild disease". [PDF]
Cohen-Cymberknoh M.
europepmc +1 more source
Aldehyde Dehydrogenase-2 Alleviates Septic Myocardial Injury by Inhibiting Caspase-11-Mediated Noncanonical Pyroptosis. [PDF]
Liang H +7 more
europepmc +1 more source
Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial. [PDF]
Durham L +5 more
europepmc +1 more source
Cepharanthine inhibits the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma via HMGA2/FOXL2 axis. [PDF]
Huang Y, Huang J, Zhang X.
europepmc +1 more source
Target-Guided Design and Synthesis of Aryl-Functionalized Promysalin Analogs. [PDF]
Golden MM, Brzezinski CU, Wuest WM.
europepmc +1 more source
Piperine and Tabersonine, but Not Lupinine, Inhibit <i>S. proteamaculans</i> Invasion of M-HeLa Cells. [PDF]
Bozhokina E, Berson Y, Tsaplina O.
europepmc +1 more source
Understanding beliefs about elexacaftor-tezacaftor-ivacaftor therapy in adults living with cystic fibrosis. [PDF]
O'Leary C +5 more
europepmc +1 more source
Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guard. [PDF]
Evans IES +8 more
europepmc +1 more source

